The prediagnostic phase of Parkinson's disease.
Ontology highlight
ABSTRACT: The field of prediagnostic Parkinson's disease (PD) is fast moving with an expanding range of clinical and laboratory biomarkers, and multiple strategies seeking to discover those in the earliest stages or those 'at risk'. It is widely believed that the highest likelihood of securing neuroprotective benefit from drugs will be in these subjects, preceding current point of diagnosis of PD. In this review, we outline current knowledge of the prediagnostic phase of PD, including an up-to-date review of risk factors (genetic and environmental), their relative influence, and clinical features that occur prior to diagnosis. We discuss imaging markers across a range of modalities, and the emerging literature on fluid and peripheral tissue biomarkers. We then explore current initiatives to identify
SUBMITTER: Noyce AJ
PROVIDER: S-EPMC4975823 | biostudies-literature | 2016 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA